Printed from Voxsanity (voxsanity.com.au) — NCT06542549 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.
Back to Ovarian Cancer
Phase 3 Ovarian Cancer Trial, Not Yet Recruiting
NCT06542549
voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice
Who may and may not be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who may be able to join
- People who are willing to sign a consent form agreeing to take part in the study.
- Women aged 18 to 74 years old.
- Women who have been diagnosed through a tissue sample (biopsy or similar procedure) with a specific type of ovarian, peritoneal, or fallopian tube cancer (high-grade serous, endometrial, or clear cell types), at an advanced stage (FIGO 2018 stage III or IV).
- Women whose cancer meets one of these conditions: a medical team has determined that complete surgical removal of the tumour is unlikely; or the person is not well enough to safely undergo major surgery straight away; or no prior cancer treatment has been received for ovarian cancer (including surgery, chemotherapy, radiotherapy, targeted therapy, or immunotherapy).
- People who have at least one tumour that can be measured on scans, according to standard measurement guidelines (RECIST version 1.1).
- People with a general physical fitness score of 0, 1, or 2 on the ECOG scale, which means they are able to carry out daily activities to varying degrees (confirm with trial site).
- People whose expected survival is longer than 12 weeks.
- People whose heart, liver, kidneys, and other organs are working well enough to meet the trial's requirements (confirm with trial site for specific thresholds).
- Women of reproductive age who agree to use effective contraception throughout the trial, and whose pregnancy test (blood or urine) comes back negative before joining.
- Women who are not currently breastfeeding.
Who may not be able to join
Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.
- People whose ovarian, fallopian tube, or peritoneal cancer is not of the epithelial type (for example, germ cell tumours), or whose tumour is classified as borderline (low malignant potential).
- People who have had, or currently have, another cancer diagnosed within the past 5 years — with some exceptions, such as certain skin cancers, superficial bladder cancer, cervical cancer in situ, breast cancer in situ, or breast cancer with no recurrence for more than 3 years after full surgical treatment.
- People with active hepatitis B or C infection, or those who carry the hepatitis B virus with virus levels above a certain threshold in their blood; people with cured hepatitis C (with negative virus levels in the blood) may be considered eligible (confirm with trial site).
- People who have tested positive for HIV or have been diagnosed with AIDS.
- People with an active or potentially recurring autoimmune disease — though some conditions may be acceptable, such as vitiligo, hair loss, or mild skin conditions not needing ongoing treatment, stable thyroid conditions managed with hormone therapy, or type 1 diabetes managed with a stable insulin dose.
- People who have had a severe allergic reaction to any monoclonal antibody or to ingredients in the drugs being tested in this trial.
- People with known active tuberculosis (TB), or suspected active TB that has not been ruled out through examination; people with known active syphilis infection.
- People who have had, or currently have, a non-infectious lung inflammation condition (such as pneumonitis or interstitial lung disease) that has required treatment with steroid medications.
- People who had a serious infection in the 4 weeks before starting the trial, including infections that required hospital admission or intravenous antibiotics in the 2 weeks before starting (not including hepatitis B or C antiviral treatment).
- People with serious non-cancer medical conditions — such as neurological disorders, psychiatric conditions, active infections, or significant abnormal test results — that the trial doctor believes would make participation unsafe.
- People with significant heart or blood vessel disease (confirm with trial site for specific conditions).
- People whom the trial doctor considers unsuitable for the study for any other reason.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Status
Not Yet Recruiting
Phase
Phase 3
Sponsor
Anhui Provincial Hospital
Registry
ClinicalTrials.gov
Start date
1 October 2024
Est. completion
31 October 2027
Primary endpoints
R0 rate
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.
Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.